Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.
about
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey.
P2860
Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Persistent immune alterations ...... patients with Gaucher disease.
@ast
Persistent immune alterations ...... patients with Gaucher disease.
@en
type
label
Persistent immune alterations ...... patients with Gaucher disease.
@ast
Persistent immune alterations ...... patients with Gaucher disease.
@en
prefLabel
Persistent immune alterations ...... patients with Gaucher disease.
@ast
Persistent immune alterations ...... patients with Gaucher disease.
@en
P2093
P1476
Persistent immune alterations ...... patients with Gaucher disease.
@en
P2093
Chidima Ioanou
Gerald E Marti
Margarita M Ivanova
Matthew Plassmeyer
Oral Alpan
Ozlem Goker-Alpan
Søren Ulrik Sønder
P356
10.1016/J.BCMD.2016.02.003
P577
2016-02-15T00:00:00Z